HIV is a virus which attacks the immune system and causes a lifelong severe illness with a long incubation period. HIV disease can be managed by treatment regimens composed of a combination of three or more antiretroviral (ARV) drugs. The product is intended for use as an aid in the management of HIV1-infected individuals undergoing antiviral therapy, together with patient’s clinical data and other laboratory test results. HIV1 ELITe MGB® Kit is a quantitative assay for the detection and quantification of the RNA of Human immunodeficiency virus type 1 (HIV1) in RNA samples extracted from clinical specimens. The assay is able to detect the RNA of HIV1 belonging to group M (subtypes A, B, C, D, F, G, H, J, K, L), group O, group N and major CRF subtypes CRF01-AE, CRF02-AG and CRF03-AB.The assay is validated in association with ELITe InGenius® system starting from human plasma samples collected in EDTA or in ACD.
Benefits
Conserved targets
Integrase Region -Polymerase domain
Internal Control: genomic RNA of MS2 phage (exogenous Internal Control)
Easy-to-use
Monoreagents, ready to use (Master Mix, standards curve and controls)
Best-in class PCR technology
ELITe MGB® probes designed with Minor Groove Binder technology, Superbases® and Eclipse® Dark Quencher
Integrated workflow
Fully automated process for extraction, amplification and result analysis with ELITe InGenius
Limit of detection: 60 IU/ml – 26 copies/ml
Eluate storage
Additional testing including multiple PCR from the same eluate, retesting or archiving
Minimal hands-on time